Phase I trial of selenium plus chemotherapy in gynecologic cancers.

Autor: Song M; Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, United States., Kumaran MN; Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, United States., Gounder M; Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, United States., Gibbon DG; Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, United States., Nieves-Neira W; Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, United States., Vaidya A; Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, United States., Hellmann M; Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, United States., Kane MP; Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, United States., Buckley B; Rutgers Environmental and Occupational Health Sciences Institute, 170 Frelinghuysen Road, Piscataway, NJ 08854, United States., Shih W; Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, United States., Caffrey PB; Department of Biological Sciences, Rutgers University, 195 University Avenue, Newark, NJ 07102, United States; Department of Biological and Environmental Sciences, 250 University Avenue, California University of PA, California, PA 15419, United States., Frenkel GD; Department of Biological Sciences, Rutgers University, 195 University Avenue, Newark, NJ 07102, United States., Rodriguez-Rodriguez L; Rutgers Cancer Institute of New Jersey, 195 Little Albany Street, New Brunswick, NJ 08903, United States; Rutgers-Robert Wood Johnson Medical School, Department of Obstetrics, Gynecology and Reproductive Sciences, 125 Paterson Street, New Brunswick, NJ 08901, United States. Electronic address: rodriglo@cinj.rutgers.edu.

Publikováno v: Gynecologic oncology [Gynecol Oncol] 2018 Sep; Vol. 150 (3), pp. 478-486. Date of Electronic Publication: 2018 Jul 29.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Model of the Development of Cisplatin Resistance in Human Small Cell Lung Cancer Xenografts.

Autor: Caffrey PB; Department of Biological and Environmental Sciences, California University of PA, California, PA, U.S.A. caffrey@calu.edu., Frenkel GD; Department of Biological Sciences, Rutgers University, Newark, NJ, U.S.A., McAndrew KL; Department of Biological and Environmental Sciences, California University of PA, California, PA, U.S.A., Marks K; Magee Women's Research Institute, University of Pittsburgh Medical Center, Pittsburgh, PA, U.S.A.

Publikováno v: In vivo (Athens, Greece) [In Vivo] 2016 11-12; Vol. 30 (6), pp. 745-749.

Prevention of carboplatin-induced resistance in human ovarian tumor xenografts by selenite.

Autor: Caffrey PB; Department of Biological and Environmental Sciences, California University of Pennsylvania, 250 University Avenue, California, PA, 15301 U.S.A. caffrey@calu.edu., Frenkel GD

Publikováno v: Anticancer research [Anticancer Res] 2013 Oct; Vol. 33 (10), pp. 4249-54.

Prevention of the development of melphalan resistance in vitro by selenite.

Autor: Caffrey PB; Department of Biological Sciences, Rutgers University, Newark, NJ 07102, USA., Zhu M, Frenkel GD

Publikováno v: Biological trace element research [Biol Trace Elem Res] 1998 Dec; Vol. 65 (3), pp. 187-95.